Biomedical Engineering Reference
In-Depth Information
[170] Z. Jakopin, R. Roskar and M. S. Dolenc, Synthesis of 3,5-disubstituted 1,2,4-
oxadiazoles as peptidomimetic building blocks,
Tetrahedron Lett
., 48, 1465-
1468 (2007).
[171] J. Cesar and M. Sollner, Use of 3,5-disubstituted 1,2,4-triazoles for the synthesis of
peptidomimetics,
Synthetic Commun
., 30, 4147-4158 (2000).
[172] D. D. Beusen, J. Zabrocki, U. Slomczynska, R. D. Head, J. L. F. Kao and
G. R. Marshall, Conformational
M
imicry -
S
ynthesis and
S
olution
C
onformation
of
AC
yclic
S
omatostatin
H
exapeptide
C
ontaining
AT
etrazole
C
is
A
mide
B
ond
S
urrogate,
Biopolymers
, 36, 181-200 (1995).
[173] V. Brecx, P. Verheyden and D. Tourw ยด, Alpha-Bn-o-AMPA as a cis peptide bond
mimic in somatostatin analogues,
Lett.Pept.Sci
., 5, 67-70 (1998).
[174] A. D. Abell, Heterocyclic-based peptidomimetics,
Lett.Pept.Sci
., 8, 267-272 (2002).
[175] J. K. Pokorski, L. M. M. Jenkins, H. Q. Feng, S. R. Durell, Y. W. Bai and
D. H. Appella, Introduction of a triazole amino acid into a peptoid oligomer induces
turn formation in aqueous solution,
Org.Lett
., 9, 2381-2383 (2007).
[176] V. D. Bock, D. Speijer, H. Hiemstra and J. H. van Maarseveen, 1,2,3-triazoles as
peptide bond isosteres: synthesis and biological evaluation of cyclotetrapeptide
mimics,
Org.Biomol.Chem
., 5, 971-975 (2007).
[177] A. K. Ghosh, P. R. Sridhar, N. Kumaragurubaran, Y. Koh, I. T. Weber and
H. Mitsuya, Bis-tetrahydrofuran: a privileged ligand for darunavir and a new
generation
of
HIV
protease
inhibitors
that
combat
drug
resistance,
ChemMedChem
, 1, 939 ff. (2006).
[178] A. Brik and C. H. Wong, HIV-1 protease: mechanism and drug discovery,
Org.Biomol.Chem
., 1, 5-14 (2003).
[179] B. B. Scott, G. M. McGeehan and R. K. Harrison, Development of inhibitors of the
aspartyl protease renin for the treatment of hypertension,
Curr.Protein Pept.Sc
., 7,
241-254 (2006).
[180] A. K. Ghosh, G. Bilcer, C. Harwood, R. Kawahama, D. Shin, K. A. Hussain,
L. Hong, J. A. Loy, C. Nguyen, G. Koelsch, J. Ermolieff and J. Tang, Structure-
based design: Potent inhibitors of human brain memapsin 2 (beta-secretase),
J.Med.Chem
., 44, 2865-2868 (2001).
[181] M. C. Maillard, R. K. Hom, T. E. Benson, J. B. Moon, S. Mamo, M. Bienkowski,
A. G. Tomasselli, D. D. Woods, D. B. Prince, D. J. Paddock, T. L. Emmons,
J. A. Tucker, M. S. Dappen, L. Brogley, E. D. Thorsett, N. Jewett, S. Sinha and
V. John, Design, synthesis, and crystal structure of hydroxyethyl secondary amine-
based
peptidomimetic
inhibitors
of
human
beta-secretase,
J.Med.Chem
., 50,
776-781 (2007).
[182] H. J. Lee, H. M. Park and K. B. Lee, The beta-turn scaffold of tripeptide containing
an azaphenylalanine residue,
Biophys.Chem
., 125, 117-126 (2007).
[183] D. Boeglin and W. D. Lubell, Aza-amino acid scanning of secondary structure suited
for solid-phase peptide synthesis with Fmoc chemistry and aza-amino acids with
heteroatomic side chains,
J.Comb.Chem
., 7, 864-878 (2005).
[184] E. Wieczerzak, S. Rodziewicz-Motowidlo, E. Jankowska, A. Gieldon and
J. Ciarkowski, An enormously active and selective azapeptide inhibitor of cathespin
B, J.Pept.Sci
., 13, 536-543 (2007).
[185] R. J. Simon, R. S. Kania, R. N. Zuckermann, V. D. Huebner, D. A. Jewell,
S. Banville, S. Ng, L. Wang, S. Rosenberg, C. K. Marlowe, D. C. Spellmeyer,
Search WWH ::
Custom Search